For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood glucose. Hyperglycaemia, also called raised blood glucose or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, especially the nerves and blood vessels. Diabetes is accelerating at an alarming rate globally. Today, over 475 million people across all age groups and social classes, live with the chronic condition. What is even more worrying is the fact that this mostly goes undetected until it reaches life-threatening proportions. The global diabetes care devices market size is projected to grow by USD 14.5 billion from 2023 to 2029, registering a CAGR of 6.7 percent, according to a new report by Gen Consulting Company.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global diabetes care devices market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for diabetes care devices can be segmented by product: blood glucose monitoring devices, insulin delivery devices. The insulin delivery devices segment was the largest contributor to the global diabetes care devices market in 2022. Diabetes care devices market is further segmented by end user: hospital & diagnostic center, homecare, others. According to the research, the hospital & diagnostic center segment had the largest share in the global diabetes care devices market. Based on region, the diabetes care devices market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2022.
The blood glucose monitoring devices market is further segmented into continuous glucose monitoring (CGM), self-monitoring blood glucose (SMBG). The self-monitoring blood glucose (SMBG) segment is estimated to account for the largest share of the global diabetes care devices market. Furthermore, the SMBG market has been categorized into glucometer devices, lancets, test strips. The CGM market is further divided into durables, sensors. The insulin delivery devices market is further segmented into insulin pens, insulin pumps, insulin syringes, others. The insulin pens segment is estimated to account for the largest share of the global diabetes care devices market.
Market Segmentation
By product: blood glucose monitoring devices, insulin delivery devices
By end user: hospital & diagnostic center, homecare, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report explores the recent developments and profiles of key vendors in the Global Diabetes Care Devices Market, including Abbott Laboratories, Acon Laboratories Inc., AgaMatrix Inc., ARKRAY, Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton, Dickinson and Company (BD), Beijing Yicheng Bioelectronics Technology Co., Ltd., Bionime Corporation, DexCom, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Health & Life Co., Ltd., Hindustan Syringes & Medical Devices Ltd. (HMD), Insulet Corporation, i-SENS, Inc., Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), Johnson & Johnson, Medisana Far East Ltd., Medtronic plc, Nipro Corporation, Novo Nordisk A/S, Sanofi S.A., Sinocare Inc., Tandem Diabetes Care, Inc., Terumo Corporation, Trividia Health, Inc., Ypsomed Holding AG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
- To analyze and forecast the market size of the global diabetes care devices market.
- To classify and forecast the global diabetes care devices market based on product, end user, region.
- To identify drivers and challenges for the global diabetes care devices market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global diabetes care devices market.
- To identify and analyze the profile of leading players operating in the global diabetes care devices market.
Why Choose This Report
- Gain a reliable outlook of the global diabetes care devices market forecasts from 2023 to 2029 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.